1. Biphenyl scaffold for the design of NMDA-receptor negative modulators: molecular modeling, synthesis, and biological activity
- Author
-
Dmitry S. Karlov, Nadezhda S. Temnyakova, Dmitry A. Vasilenko, Oleg I. Barygin, Mikhail Y. Dron, Arseniy S. Zhigulin, Elena B. Averina, Yuri K. Grishin, Vladimir V. Grigoriev, Alexey V. Gabrel'yan, Viktor A. Aniol, Natalia V. Gulyaeva, Sergey V. Osipenko, Yury I. Kostyukevich, Vladimir A. Palyulin, Petr A. Popov, and Maxim V. Fedorov
- Subjects
Pharmacology ,Chemistry ,Organic Chemistry ,Drug Discovery ,Pharmaceutical Science ,Molecular Medicine ,Biochemistry - Abstract
NMDA (N-methyl-d-aspartate) receptor antagonists are promising tools for the treatment of a wide variety of central nervous system impairments including major depressive disorder. We present here the activity optimization process of a biphenyl-based NMDA negative allosteric modulator (NAM) guided by free energy calculations, which led to a 100 times activity improvement (IC(50) = 50 nM) compared to a hit compound identified in virtual screening. Preliminary calculation results suggest a low affinity for the human ether-a-go-go-related gene ion channel (hERG), a high affinity for which was earlier one of the main obstacles for the development of first-generation NMDA-receptor negative allosteric modulators. The docking study and the molecular dynamics calculations suggest a completely different binding mode (ifenprodil-like) compared to another biaryl-based NMDA NAM EVT-101.
- Published
- 2022
- Full Text
- View/download PDF